Hsiao Lieu
Direttore Tecnico/Scientifico/R&S presso NGM BIOPHARMACEUTICALS, INC.
Patrimonio netto: 55 499 $ in data 31/03/2024
Posizioni attive di Hsiao Lieu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NGM BIOPHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2019 | - |
| The University of California, San Francisco | Corporate Officer/Principal | - | - |
Storia della carriera di Hsiao Lieu
Precedenti posizioni note di Hsiao Lieu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/11/2017 | 01/03/2019 |
| PORTOLA PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/01/2008 | 01/01/2008 |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2006 | 01/01/2006 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
| Retinorx LLC | Amministratore Delegato | - | - |
| Fondatore | - | - | |
| CAPRICOR THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 01/03/2008 | - |
Formazione di Hsiao Lieu
| New York University | Undergraduate Degree |
| Yeshiva University | Doctorate Degree |
| Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 12 |
Posizioni
| Chief Tech/Sci/R&D Officer | 4 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Settori
| Health Technology | 7 |
| Consumer Services | 5 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| NGM BIOPHARMACEUTICALS, INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| Aziende private | 4 |
|---|---|
CV Therapeutics, Inc.
CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
| Retinorx LLC | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
- Borsa valori
- Insiders
- Hsiao Lieu
- Esperienza
